Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Rxsight Inc (RXST)

Rxsight Inc (RXST)
13.90 x 1 N/A x N/A
Post-market by (Cboe BZX)
14.08 -0.11 (-0.78%) 04/11/25 [NASDAQ]
13.90 x 1 N/A x N/A
Post-market 13.91 -0.17 (-1.21%) 18:12 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
13.50
Day High
14.56
Open 14.31
Previous Close 14.19 14.19
Volume 1,102,400 1,102,400
Avg Vol 1,108,195 1,108,195
Stochastic %K 5.13% 5.13%
Weighted Alpha -74.04 -74.04
5-Day Change -2.18 (-13.41%) -2.18 (-13.41%)
52-Week Range 13.50 - 66.54 13.50 - 66.54
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 570,113
  • Shares Outstanding, K 40,491
  • Annual Sales, $ 139,930 K
  • Annual Income, $ -27,460 K
  • EBIT $ -37 M
  • EBITDA $ -42 M
  • 60-Month Beta 1.26
  • Price/Sales 4.11
  • Price/Cash Flow N/A
  • Price/Book 2.03

Options Overview Details

View History
  • Implied Volatility 94.89% ( -28.93%)
  • Historical Volatility 145.80%
  • IV Percentile 94%
  • IV Rank 48.97%
  • IV High 153.08% on 08/05/24
  • IV Low 39.03% on 05/22/24
  • Put/Call Vol Ratio 0.27
  • Today's Volume 28
  • Volume Avg (30-Day) 652
  • Put/Call OI Ratio 1.64
  • Today's Open Interest 12,914
  • Open Int (30-Day) 6,780

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.16
  • Number of Estimates 3
  • High Estimate -0.10
  • Low Estimate -0.19
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +36.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.50 +4.30%
on 04/11/25
Period Open: 25.44
27.13 -48.10%
on 03/27/25
-11.36 (-44.65%)
since 03/11/25
3-Month
13.50 +4.30%
on 04/11/25
Period Open: 33.43
34.71 -59.44%
on 02/04/25
-19.35 (-57.88%)
since 01/10/25
52-Week
13.50 +4.30%
on 04/11/25
Period Open: 55.31
66.54 -78.84%
on 05/07/24
-41.23 (-74.54%)
since 04/11/24

Most Recent Stories

More News
Stock Losses Deepen on China Retaliatory Tariffs

The S&P 500 Index ($SPX ) (SPY ) today is down -2.89%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -2.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.83%. June E-mini S&P futures...

DD : 58.89 (+2.13%)
GOOGL : 157.14 (+2.83%)
RXST : 14.08 (-0.78%)
AAPL : 198.15 (+4.06%)
ADI : 179.16 (+0.45%)
MKTX : 221.81 (+5.46%)
BIDU : 82.73 (+5.43%)
SLB : 33.96 (+4.36%)
WYNN : 73.19 (+1.23%)
CLX : 141.44 (+0.38%)
OXY : 37.67 (+3.29%)
TSLA : 252.31 (-0.04%)
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance

RXST : 14.08 (-0.78%)
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

RXST : 14.08 (-0.78%)
RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance

RXST : 14.08 (-0.78%)
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025

RXST : 14.08 (-0.78%)
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

RXST : 14.08 (-0.78%)
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

RXST : 14.08 (-0.78%)
Insider Sale: See remarks of $RXST (RXST) Sells 3,105 Shares

Ilya Goldshleger, the See remarks of $RXST ($RXST), sold 3,105 shares of the company on 11-29-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.8% of their...

RXST : 14.08 (-0.78%)
Insider Sale: Director at $RXST (RXST) Sells 3,782 Shares

Shweta Maniar, a director at $RXST ($RXST), sold 3,782 shares of the company on 11-26-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 25.8% of their shares....

RXST : 14.08 (-0.78%)
RxSight, Inc. Reports Third Quarter 2024 Financial Results

RXST : 14.08 (-0.78%)

Business Summary

RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens(R), RxSight Light Delivery Device and accessories. RxSight Inc. is based in ALISO VIEJO, Calif.

See More

Key Turning Points

3rd Resistance Point 15.65
2nd Resistance Point 15.11
1st Resistance Point 14.59
Last Price 14.08
1st Support Level 13.53
2nd Support Level 12.99
3rd Support Level 12.47

See More

52-Week High 66.54
Fibonacci 61.8% 46.28
Fibonacci 50% 40.02
Fibonacci 38.2% 33.76
Last Price 14.08
52-Week Low 13.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar